Biological understanding of top genetic alterations across tumor types
Validation and characterization of potential cancer driver genes
Functional profiling and molecular profiling of subtype-specific cancer cell lines
Testing small molecules or biologics for cancer drug development
Type Strain
no
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Comments
A panel of 8 bladder tumor cell lines with varying degrees of genetic complexity. Each culture contains genomic mutations in one or more of the following genes according to the Sanger COSMIC database: PIK3CA, RB1, RAS, TSC1, CDKN2A, PTEN, and TP53.
